For best results when printing this announcement, please click on the linkbelow:
  http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130128:nPnSF42075
 Multi-Billion Dollar New All-Digital Medical Facility to Implement Omnicell'sAdvanced Medication Automation Solutions in QatarMOUNTAIN VIEW, Calif.,  Jan. 28, 2013  /PRNewswire/ --  Omnicell, Inc.(NASDAQ:OMCL), a leading provider of medication and supply management solutionsand analytics software for healthcare facilities and its partner, MannaiCorporation, today announced that the highly anticipated, all-digital  SidraMedical and Research Center  has selected Omnicell as the exclusive provider ofautomated medication management solutions throughout its facility. Omnicell's G4platform will serve as an integral component of Sidra's planned wireless andvirtually paperless nursing and pharmacy operations. Sidra's mission is toprovide world-class patient care along with medical education and research. Tosupport the achievement of these goals, the Qatar Foundation has committed  $7.9billion, one of the largest endowments of its kind in the world.(Logo:  
  http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a
 )After a competitive global review process of the most advanced medicationautomation technology, Omnicell's G4 platform was selected for its uniquecapabilities and overall patient safety benefits. Omnicell's highlyinteroperable solutions and advanced technology perfectly complement Sidra'sgoals of empowering providers through easier access to information, enabling thehighest possible quality of patient care.  "As we strive to establish Sidra as one of the most modern medical facilities inthe world, it is vital that we implement a medication automation solution thatwill integrate effortlessly with our other care delivery processes and systems,"said Sidra's chief of health informatics Dr.  Alistair Erskine. "We selectedOmnicell's technologically advanced solutions because we are confident that thiswill help fulfill our vision of providing truly exceptional patient care.Omnicell, with its experience in the region, is an important relationship forSidra as we build and strengthen our reputation as a leader in health care,medical research and academic medical training throughout the  Middle East. Welook forward to cooperating with Omnicell for many years to come."Sidra will open with around 400 beds while putting infrastructure in place toenable expansion to 550 beds in a subsequent phase. Sidra plans to use Omnicelltechnologies throughout the facility and intends to increase deployment overtime to meet the hospital's growing needs as it expands.  In addition to theOmniRx G4 automated medication dispensing cabinets (ADCs), the followingOmnicell technologies will be implemented:  * Omnicell's Anesthesia Workstation, an automated dispensing cabinet thatimproves medication security in the operating room without sacrificingconvenient access to medications and supplies.  * Savvy, a mobile medication workstation designed to streamline the medicationadministration process and provide safe and secure transportation of medicationsfrom the ADC to the patient's bedside, helping nurses administer medicationsmore quickly, saving time for other patient care tasks.  * Anywhere RN  remote medication management software, which provides nurses witha flexible approach to the medication administration process that positivelyimpacts nursing and patient safety. It is a web-based application designedspecifically for nurses that lets them remotely access the Omnicell cabinetsfrom virtually any computer or workstation in the patient care area, includingthe Savvy mobile medication workstation.  Study data shows that with Anywhere RN running on Savvy mobile medicationsystems or networked workstations, nurses are interrupted on average 54 percentless during critical medication administration procedures, and they also spendan average of 33 percent less time doing administrative duties at the dispensingcabinet.  Nurses are thus freed to spend more time focusing on their clinicalwork and spending time with their patients.  1  "Omnicell is confident that Sidra's commitment to providing outstanding patientcare through the use of the most innovative technologies will quickly propelthem to become one of the  Middle East's top health facilities. We are honoredto be selected to work with this groundbreaking medical center, furthering ourcommitment to work with world-class healthcare facilities in this rapidlygrowing region of the world," said  Gary Ervin, Vice President International, atOmnicell. "As an all-digital facility, the integration of data and workflowsbetween technologies is imperative to Sidra's success, and we are pleased tooffer a solution that can meet their needs."  "Espousing Sidra Medical Research Center's mission to provide world-classpatient care, we are extremely proud to be partnering with Omnicell to bring ina top-notch pharmacy automation solution, which maximizes medication safety andworkflow efficiency," said  Alekh Grewal, Group CEO, Mannai Corporation. "Sinceits inception, Mannai Medical Division, with its team of certified delivery andsupport professionals, has been constantly striving to provide state-of-the-artmedical and scientific technology solutions which are in line with  Qatar'svision to promote quality health care for its people."About Sidra Medical & Research CenterSidra Medical and Research Center is a groundbreaking hospital, research andeducation institution, currently under construction in  Doha, Qatar, that willfocus on the health and wellbeing of women and children regionally and globally.Sidra will be a fully digital facility, incorporating the most advancedinformation technology applications in clinical, research and businessfunctions. Sidra will initially have around 400 beds with infrastructure toenable expansion to 550 beds in a subsequent phase.Sidra represents the vision of Her Highness Sheikha Moza bint Nasser who servesas its Chairperson. The high-tech facility will not only provide world-classpatient care but will also help build  Qatar's scientific expertise andresources. Sidra will be funded by a  US$7.9 billion  endowment from QatarFoundation, one of the largest endowments of its kind in the world.Sidra is part of a dynamic research and education environment in  Qatar  thatincludes leading international institutions, such as: Sidra's academic partner Weill Cornell Medical College in Qatar, and Qatar Science and Technology Park.Through strong partnerships with leading institutions around the world, Sidra iscreating an intellectual ecosystem to help advance scientific discovery throughinvestment in medical research.  Sidra will have a unique working structure with inter-professional collaborationat the heart, providing the best holistic care for patients and an unparalleledlearning environment for its medical professionals. Sidra will combine the bestin design, technology, operations and practices from medical centers around theworld - to offer its employees an environment that is at once familiar andextraordinary.  About Mannai Corporation Q.S.C.  Mannai Corporation Q.S.C. is a public company headquartered in  Qatar  with over3,000 employees. Its diverse range of business areas include automotivedistribution and service, information and communication technology, engineeringservices to the oil and gas sector, home appliances and electronics, travelservices, logistics, geotechnical and geological services, facilitiesmanagement, trading and commercial representation.In the healthcare sector, Mannai Medical division offers healthcare equipmentand systems from some of the world's leading healthcare technology providers andoffers installation, commissioning, application support and post-warrantyservices. A number of turnkey projects have been deployed in hospitals thatinclude complete Medical Gas Pipeline Systems (MGPS), Medical ArchitecturalSystem, Pneumatic Tube Systems (PTS), Automated Guided Vehicles (AGV),Diagnostic Imaging Systems and Monitoring Devices, Scientific and LaboratorySystems among others.   Please visit  
  www.mannai.com
   for more information.About OmnicellFor over 20 years the mission of Omnicell (NASDAQ: OMCL) has been creating newefficiencies to improve patient care, anywhere it is delivered. Omnicell is aleading supplier of comprehensive automation and business analytics softwaresolutions for patient-centric medication and supply management across the
 entirehealthcare continuum, from the acute care hospital setting to post-acute skillednursing and long-term care facilities to the home.Since 1992, more than 2,600 Acute Care customers worldwide have utilizedOmnicell's medication automation, supply chain and analytics solutions toincrease operational efficiency, reduce errors, deliver actionable intelligenceand improve patient safety. Omnicell Non-Acute Care solutions, under the MTSMedication Technologies brand, provide innovative medication adherence packagingsolutions that can reduce costly hospital readmissions and enable approximately6,000 institutional and retail pharmacies worldwide to maintain high accuracyand quality standards in medication dispensing and administration whileoptimizing productivity and controlling costs.  1Data from Omnicell nursing surveys  OMCL - GSOURCE  Omnicell, Inc.Todd Sims, Omnicell, Inc., +1-650-251-6114, todd.sims@omnicell.com; or GloriaMontefalcon, Mannai Corporation, +974 44558868, montefalcon@mannai.com.qa